 D75 |
 |
Other and unspecified diseases of blood and blood-forming organs  |
| |
| Excludes2 |
acute lymphadenitis (L04.-)
chronic lymphadenitis (I88.1)
enlarged lymph nodes (R59.-)
hypergammaglobulinemia NOS (D89.2)
lymphadenitis NOS (I88.9)
mesenteric lymphadenitis (acute) (chronic) (I88.0)
|
|
| |
 D75.0 |
|
Familial erythrocytosis |
| |
| Benign polycythemia | | Familial polycythemia |
| Excludes1 |
hereditary ovalocytosis (D58.1)
|
|
|
| |
| D75.1 |
|
Secondary polycythemia |
| |
| Acquired polycythemia | | Emotional polycythemia | | Erythrocytosis NOS | | Hypoxemic polycythemia | | Nephrogenous polycythemia | | Polycythemia due to erythropoietin | | Polycythemia due to fall in plasma volume | | Polycythemia due to high altitude | | Polycythemia due to stress | | Polycythemia NOS | | Relative polycythemia |
| Excludes1 |
polycythemia neonatorum (P61.1)
polycythemia vera (D45)
|
|
|
| |
| D75.8 |
|
Other specified diseases of blood and blood-forming organs |
| |
| D75.81 |
|
Myelofibrosis |
| |
| Myelofibrosis NOS | | Secondary myelofibrosis NOS |
| CodeFirst |
the underlying disorder, such as:
malignant neoplasm of breast (C50.-)
|
| UseAdditionalCode |
code, if applicable, for associated therapy-related myelodysplastic syndrome (D46.-)
|
| UseAdditionalCode |
code for adverse effect, if applicable, to identify drug (T45.1X5)
|
| Excludes1 |
acute myelofibrosis (C94.4-)
idiopathic myelofibrosis (D47.1)
leukoerythroblastic anemia (D61.82)
myelofibrosis with myeloid metaplasia (D47.4)
myelophthisic anemia (D61.82)
myelophthisis (D61.82)
primary myelofibrosis (D47.1)
|
| nonPrimary |
Yes
|
|
| | |
| D75.82 |
|
Heparin induced thrombocytopenia (HIT) |
| |
| UseAdditionalCode |
code, if applicable, for adverse effect of heparin (T45.515-)
|
|
| |
| D75.821 |
|
Non-immune heparin-induced thrombocytopenia |
| |
| Non-immune HIT | | Type 1 heparin-induced thrombocytopenia |
|
| | |
| D75.822 |
|
Immune-mediated heparin-induced thrombocytopenia |
| |
| Immune-mediated HIT | | Type 2 heparin-induced thrombocytopenia |
|
| | |
| D75.828 |
|
Other heparin-induced thrombocytopenia syndrome |
| |
| Autoimmune heparin-induced thrombocytopenia syndrome | | Delayed-onset heparin-induced thrombocytopenia | | Persisting heparin-induced thrombocytopenia |
|
| | |
| D75.829 |
|
Heparin-induced thrombocytopenia, unspecified |
| | | |
| D75.83 |
|
Thrombocytosis |
| |
| Excludes2 |
essential thrombocythemia (D47.3)
|
|
| |
| D75.838 |
|
Other thrombocytosis |
| |
| Reactive thrombocytosis | | Secondary thrombocytosis |
| CodeAlso |
underlying condition, if known and applicable
|
|
| | |
| D75.839 |
|
Thrombocytosis, unspecified |
| |
| Thrombocythemia NOS | | Thrombocytosis NOS |
|
| | | |
| D75.84 |
|
Other platelet-activating anti-PF4 disorders |
| |
| Spontaneous heparin-induced thrombocytopenia syndrome (without heparin exposure) | | Thrombosis with thrombocytopenia syndrome | | Vaccine-induced thrombotic thrombocytopenia |
| UseAdditionalCode |
code, if applicable, for adverse effect of other viral vaccine (T50.B95-)
|
|
| | |
| D75.89 |
|
Other specified diseases of blood and blood-forming organs |
| |
| |
| D75.9 |
|
Disease of blood and blood-forming organs, unspecified |
|
| |
| D75.A |
|
Glucose-6-phosphate dehydrogenase (G6PD) deficiency without anemia |
| |
| Excludes1 |
glucose-6-phosphate dehydrogenase (G6PD) deficiency with anemia (D55.0)
|
|
|